Sponsor Dossier
Ipsen
Sponsor Dossier for Ipsen. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: BYLVAY
- Brand: CABOMETYX
- Brand: DIPHERELINE
- Brand: DYSPORT
- Brand: IQIRVO
- Brand: RELFYDESS
- Brand: SOHONOS
- Brand: SOMATULINE AUTOGEL
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
About
Ipsen is an Australian Private Company with ABN 47095036909, registered in Victoria. The entity is active and registered for GST.
Portfolio
Ipsen has eight brands on the ARTG, all of which are indexable. All eight brands have Product Information on file. Three brands are PBS-listed, seven have PBAC outcomes on record, and five have AusPARs on record. Notable brands include BYLVAY, CABOMETYX, DIPHERELINE, DYSPORT, IQIRVO, RELFYDESS, SOHONOS, and SOMATULINE AUTOGEL.
Therapeutic focus
— Oncology: 3 brands — Gastroenterology: 2 brands — Dermatology: 1 brand — Neurology: 1 brand — Rare Disease: 1 brand
PBS footprint
Three brands in Ipsen's portfolio are PBS-listed, with the latest PBS schedule date their portfolio touched being 1 May 2026.
Regulatory activity
Ipsen's latest PBAC outcome is from 1 July 2025, with seven brands holding PBAC outcomes on record. The latest AusPAR is from 18 March 2025, with five brands holding AusPARs on record.